Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.
about
Proton pump inhibitors and gastritisHelicobacter pyloriRole of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing countryHelicobacter pylori and gastric acid: an intimate and reciprocal relationshipLaser assisted ratio analyser 13C-urea breath testing, for the detection of H. pylori: A prospective diagnostic European multicentre study.Omeprazole attenuates neutrophil-endothelial cell adhesive interaction induced by extracts of Helicobacter pylori.Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy.Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.Elevated risk for gastric adenocarcinoma can be predicted from histomorphology.Helicobacter pylori modulation of gastric acid.Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux diseaseReview article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.Review article: is Helicobacter pylori status relevant in the management of GORD?Helicobacter pylori infection among patients with upper gastrointestinal symptoms: prevalence and relation to endoscopy diagnosis and histopathology.Trends, controversies and contradictions in the management of gastroesophageal reflux disease patients.Adverse effects of long-term proton pump inhibitor therapy.Gastroesophageal reflux and Helicobacter pylori: a review.Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.The use of a second biopsy from the gastric body for the detection of Helicobacter pylori using rapid urease test.Diagnosis of Helicobacter pylori by invasive test: histology.Evaluation of urine ELISA test for detecting Helicobacter pylori infection in Taiwan: a prospective study.Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse modelDiagnostic methods for Helicobacter pylori detection and eradicationEradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatmentHelicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradicationEffect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?Acid suppression and gastric atrophy: sifting fact from fictionCure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trialHelicobacter pylori independent chronological change in gastric acid secretion in the Japanese.Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.Upper gastrointestinal endoscopy in Malawi: an opportunityRole of pantoprazole in the treatment of gastro-oesophageal reflux disease.Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis.Real-world Helicobacter pylori diagnosis in patients referred for esophagoduodenoscopy: The gap between guidelines and clinical practice.Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
P2860
Q24655315-02FF65F0-D73D-4437-B562-DC9328D2A74AQ24683623-D785F174-CF84-42A5-A16A-BA39FCAA39AEQ24813062-3E7DDFF9-AE14-4F3C-BAFE-DE68FD6A6317Q28077416-306A07A0-4B8D-47AF-B178-5A3B1A2CB03BQ30762104-1100A0C9-82FC-4537-8715-B929B4FEFCBAQ31214165-438D8789-C691-4D6B-9591-9810F184745EQ32034890-2134B17F-B4F0-49BE-BA35-772B8AE77049Q33548205-878E23E9-24D7-40E6-89BB-B142EEA233CEQ33618258-93178600-ED15-4C1F-BC13-9EB111FF4A18Q33868964-AD9776F7-FB1B-432C-B208-2FB9636BE92AQ33898652-F4E3E85A-A228-45D7-9902-1ABC4548AF77Q33898661-9321522D-C8E8-4BD5-A77B-55500B40BEC8Q33994156-506E030D-014B-455D-B83D-105FE683274EQ34069835-4E1C0FE0-C2EB-440C-BC41-7B1E07890C15Q34072936-E8F5E9F0-7593-4578-A8CA-FD8A3B7A47B7Q34152231-71740E3A-EC25-4100-9592-0B6048BF0E62Q34167899-2E8A0415-3EAE-4184-8312-2137976354E1Q34511969-C377C71D-9ED6-46AE-9477-89FD2AFD4F02Q34605648-ED2B8D79-D399-4FC6-865F-00F5FA0EEE1CQ34929616-7792B8DF-8B9F-4536-B097-C6B69BCDC8F0Q34947173-CD4798F6-6156-48B9-B570-9646B841309AQ35059651-B5B48E24-5649-43F9-ADF1-5F1D198CE1ABQ35102815-A79CE08E-399D-461E-9D90-E0B2DA5D3D7DQ35200053-4CA35AAB-999A-4FC5-99B2-03FEA664BA96Q35349400-625F9AD4-C03E-4B42-A8F2-90505CB77162Q35354635-7EB43CB4-76AF-415B-A713-A349FBCA5C2EQ35357486-5739F4C2-17B2-4D26-8A92-734B5D5BB242Q35360155-97D2AC53-3877-4194-806B-8B697BA3A19FQ35579081-A1AF1B1D-6089-4382-B80A-E40B9CF59ABCQ35579101-B276CCC6-0ED0-4AB0-9FE5-5B8134531AF7Q35596265-2B2CC3CA-E195-4036-AA27-51FC8AFA90B3Q35841100-4A1B693A-DACD-4A91-AC0C-1AE2028C6F95Q35841377-941F3A1E-66BB-429A-AF29-61FBA126EF9CQ35938494-B1AB1AD0-7658-4FCE-B96E-EF006095C6D3Q36040702-E9B2E082-C3B3-462F-AD91-4CF70BD8794BQ36117678-68A9256E-4805-4F67-BE43-5799E5D5D60EQ37247773-C9CEDE6E-4467-4A26-A24E-94A65F606A7CQ37270979-1EE0449F-A44C-4EED-B19A-0FFD85CBA2A3Q37744612-6151ECBA-E953-402C-99D3-CADE8A6BC591Q38547653-2D29CE0F-3A42-4766-BB7E-021814ED9DEE
P2860
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Changes in the intragastric di ...... ing treatment with omeprazole.
@ast
Changes in the intragastric di ...... ing treatment with omeprazole.
@en
Changes in the intragastric di ...... ing treatment with omeprazole.
@nl
type
label
Changes in the intragastric di ...... ing treatment with omeprazole.
@ast
Changes in the intragastric di ...... ing treatment with omeprazole.
@en
Changes in the intragastric di ...... ing treatment with omeprazole.
@nl
prefLabel
Changes in the intragastric di ...... ing treatment with omeprazole.
@ast
Changes in the intragastric di ...... ing treatment with omeprazole.
@en
Changes in the intragastric di ...... ing treatment with omeprazole.
@nl
P2093
P2860
P356
P1433
P1476
Changes in the intragastric di ...... ing treatment with omeprazole.
@en
P2093
P2860
P356
10.1136/GUT.36.1.12
P407
P577
1995-01-01T00:00:00Z